<DOC>
	<DOCNO>NCT02459197</DOCNO>
	<brief_summary>The purpose clinical trial conduct patient suffer chronic pain study relationship individual patient ' profile analgesic response</brief_summary>
	<brief_title>A Proof Concept Study Investigate Effect New Treatment Patient With Chronic Pain</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<criteria>Are men woman least 18 year age Diagnosed Peripheral Neuropathic Pain ( PNP ) knee hip pain attribute Osteoarthritis ( OA ) since least 6 month Affiliated national welfare Reliable willing make available duration study willing follow study procedure Have give write informed consent approve relevant Ethics Committee ( EC ) govern study site Patients required report pain score 4 8 inclusive mean Average Pain Score ( APS ) baseline period precede randomization complete least 10 day pain assessment diary Visit 1 Visit 2 . If 10 day complete , mean APS calculate last 10 one . Inclusion Disease Criteria : Diagnosis criterium PNP : Patient chronic PNP support distinct neuroanatomical plausible distribution sensory sign symptom , consecutive one follow cause : traumatic event , surgical procedure ( exclude limb amputation ) , radiculopathy , post herpetic post zoster neuralgia , diabetic polyneuropathy post chemotherapy . Diagnosis confirm DN4 questionnaire screen visit ( pain consider neuropathic DN4 score â‰¥ 4 ) Diagnosis criterium OA : Patient unilateral bilateral OA knee hip diagnose accord American College Rheumatology ( ACR ) criterion base clinical radiographic evidence ( Altman et al . 1986 ) . The clinical diagnosis OA confirm ACR clinical radiographic criterion classification idiopathic OA knee hip base upon follow criterion : 1 . Knee hip pain average least half time last 3 month screen visit 2 . At least 1 follow 3 condition : Age &gt; 50 morning stiffness &lt; 30 minute crepitus 3 . Kellgren Lawrence grade &gt; 1 assess possible Xray refer joint confirm diagnosis . If consider medically require Investigator base patient need part regular patient management , new anteriorposterior view X ray obtain review Investigator delegate verify patient meet disease diagnostic criterion Patient change his/her `` regular analgesic therapy `` PNP OA last 4 week prior Visit 1 study . Patient 's regular analgesic treatment PNP OA consist 2 different treatment , neurostimulation consider analgesic treatment PNP . Patient report unvariable APS WPS score Visit 1 Visit 2 ( systematically APS score WPS score report ) . Use plan use nontopical corticosteroid study . Have initiate ( plan initiate ) program ( modify exist program frequency and/or intensity ) physiotherapy behavioral therapy pain selfmanagement , hypnosis , sophrology , meditation program within 2 week prior Visit 1 study . Pregnant , breastfeeding , willing pregnant within 3 month . Patients current recent history , determine Investigator , severe , progressive , and/or uncontrolled renal , hepatic , haematological , gastrointestinal , endocrine , pulmonary , cardiac , neurological , cerebral disease would interfere patient 's participation study . Uncontrolled epilepsy . Any current primary psychiatric condition , include depression personality disorder ( Axe II Diagnostic Statistical Manual Mental Disorders ( DSMIV ) ; personality disorder mental retardation ) . Alcohol dependence regular use know drug abuse ( e.g. , amphetamine , barbiturate , benzodiazepine , cannabinoids , cocaine , methadone , opiates , phencyclidine ) . Any relevant medical disorder/acute disease state judge Investigator likely interfere trial represent risk patient . Any close relationship Investigators Sponsor ( i.e . belong immediate family subordination link ) . Patient legal protection , accord national law . Are person previously receive T4P1001 , complete withdrawn study study investigate T4P1001 . Patient currently enrol clinical trial involve use investigational drug device , concurrently enrol type medical research judge scientifically medically compatible study , exclusion period accord national law . Exclusion Disease Criteria PNP patient : Neuropathic pain due trigeminal neuralgia , central pain phantom limb pain . Have initiate , plan initiate electrical stimulation ( neurostimulation ) therapy modify exist neurostimulation within 4 week prior Visit 1 study period . Exclusion disease criterion OA patient : Nonambulatory due OA . Use low extremity assistive device cane crutch walker knee brace `` shoe lift '' relation OA . Have use relation OA systemic corticosteroid 4 week prior Visit 1 ; Intramuscular corticosteroid injection Intraarticular injection steroid refer knee/hip within 3 month Visit 1 , Intraarticular injection corticosteroid site refer knee/hip within 4 week prior Visit 1 ( corticosteroid topical use allow ) . Have use viscosupplementation intra articular injection hyaluronic acid refer joint within 3 month prior Visit 1 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Pain</keyword>
</DOC>